momo-T/FIF Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : momo-T/FIF

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (11680)	9/19/2018 1:41:06 PM
From: semi_infinite	Read Replies (1) of 12215

Thx. I get that small differences in chemical structure can mean big differences in safety and I understand your concerns wrt the hedging that Viking CEO may be communicating via dosage comments. Just wondering if similar unresolved metabolite peaks were detected with MGL3196. If so, what does it say about correlation of safety outcomes with unresolved metabolite peaks on a chromatograph. researchgate.net

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next